<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC6043914/results/search/funders/results.xml">
  <result pre="conclusions .] Sofosbuvir (Sovaldi ®) received approval from the USA" exact="Food and Drug Administration" post="(FDA) in December 2013. Since then, more than a"/>
  <result pre="A rich source of antiviral agents C. K. (David) Chu," exact="University of Georgia," post="Athens, GA, USA David ( Figure 4) had known"/>
  <result pre="Lecture: Collaborating in drug discovery: Challenges and solutions Maaike Everts," exact="University of Alabama at Birmingham," post="AL, USA Maaike ( Figure 6) said that she"/>
  <result pre="and Development Consortium (AD3C). The ADDA has two participants, the" exact="University of Alabama at Birmingham" post="(UAB) and Southern Research (SR). It was Richard (Rich)"/>
  <result pre="partners in AD3C: UAB, SR, Oregon Health &amp;amp; Science University," exact="Vanderbilt University," post="Washington University in St Louis, University North Carolina at"/>
  <result pre="North Carolina at Chapel Hill, University of Colorado Denver and" exact="Gilead Sciences," post="Inc. The consortium was set up in 2014 with"/>
  <result pre="consortium was set up in 2014 with funding (U19) from" exact="National Institute of Allergy and Infectious Diseases." post="The general aims are HTS, chemistry and in vivo"/>
  <result pre="the humoral immune response to viral infection Priscilla L. Yang," exact="Harvard Medical School," post="Boston, MA, USA The underlying aim of Priscilla Yang"/>
  <result pre="St Lawrence University in 1970, and her PhD from the" exact="University of Wisconsin-Madison" post="(Biochemistry, 1975). Following two postdoctoral posts (Zurich and Madison),"/>
  <result pre="became the Principal Investigator for a NIH-funded research programme at" exact="University of Wisconsin-Madison" post="since 1978. Ann is now a Professor in the"/>
  <result pre="public health: A case study of polio Mark A. Pallansch," exact="Centers for Disease Control and Prevention," post="Atlanta, GA, USA Mark Pallansch ( Figure 9) received"/>
  <result pre="from Virginia Tech and PhD in Biochemistry (1982) from the" exact="University of Wisconsin-Madison." post="For his postdoctoral fellowship (1984), he studied persistent measles"/>
  <result pre="is Director of the Division of Viral Diseases at the" exact="Centers for Disease Control and Prevention," post="in Atlanta, Georgia. The polio laboratory at CDC serves"/>
  <result pre="(bacteriology) from Birmingham University, England (1969) and his PhD from" exact="Brunel University, London," post="England (1972) while working on tumour immunology at Imperial"/>
  <result pre="his work on retroviruses during his postdoctoral studies at the" exact="University of Southern California." post="In 1976, he joined UAB. While at UAB, Eric"/>
  <result pre="eight years. This NIH-funded work is also supported by the" exact="International AIDS Vaccine Initiative" post="(IAVI), which is a global not-for-profit organisation whose mission"/>
  <result pre="defining viral virulence. Zika antiviral and vaccine development Pei-Yong Shi," exact="University of Texas Medical Branch," post="Galveston, TX, USA. Pei-Yong Shi ( Figure 11) received"/>
  <result pre="Shi ( Figure 11) received his PhD in virology from" exact="Georgia State University" post="(1996) and then moved to Yale University for postdoctoral"/>
  <result pre="virology from Georgia State University (1996) and then moved to" exact="Yale University" post="for postdoctoral training. He moved to Bristol-Myers Squibb, working"/>
  <result pre="moved to Yale University for postdoctoral training. He moved to" exact="Bristol-Myers Squibb," post="working on HIV and HCV therapeutics, from 1998 to"/>
  <result pre="therapeutics, from 1998 to 2000. He was at Wadsworth Center," exact="New York State Department of Health," post="to study West Nile virus (2000–2008). At Novartis Institute"/>
  <result pre="to 2000. He was at Wadsworth Center, New York State" exact="Department of Health," post="to study West Nile virus (2000–2008). At Novartis Institute"/>
  <result pre="Department of Health, to study West Nile virus (2000–2008). At" exact="Novartis" post="Institute for Tropical Diseases, he was Dengue Unit Head"/>
  <result pre="(2008–2015). Currently, Pei-Yong is I.H. Kempner Professor of Human Genetics," exact="University of Texas Medical Branch," post="Galveston, Texas, USA. Having worked for many years with"/>
  <result pre="virus fusion process. I recall discussing with my friends from" exact="Roche" post="at the 1999 ICAR (Jerusalem) the use of their"/>
 </snippets>
</snippetsTree>
